The Importance of Non-Molecular Based Pharmacogenomics Testing

Over 2 million people in the United States experience adverse drug reactions annually, contributing to approximately 100,000 deaths. This fact highlights the pivotal function of non-molecular based pharmacogenomics testing within precision medicine. Such methodologies, distinct from traditional molecular analyses, enable a depth of scrutiny into an individual's drug responsiveness. This personalized approach aids in the efficacious and customized provisioning of pharmaceutical interventions.
Pharmacogenomics explore the genetic underpinnings of medication reactions. While often involving DNA assessment, non-molecular based pharmacogenomics testing broadens the diagnostic scope by incorporating diverse biological indicators. The resulting predictive insights for drug reactions outperform traditional, exclusively genetic tests. Consequently, these alternative approaches emerge as indispensable instruments in enabling precision medicine's ...